Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
In the OASIS-1 study, 13% of participants (people with obesity without diabetes) receiving oral semaglutide 50 mg experienced altered skin sensation events compared to 1% with placebo - these events were generally mild to moderate in severity, occurred during dose escalation to the higher doses and resolved without requiring permanent treatment discontinuation [21]
Use a higher concentration or split into two draws.* Recommended for 10 mg vials: Add 1 mL for 10 mg/mL
Our team consists of experienced healthcare professionals who are dedicated to providing personalized care and support throughout your peptide therapy journey
Store the lyophilized material at 20C, protected from light and moisture.
